Sign In
Buy ICCC
$11.21
+0.150 (+1.36%)
At Close: Jul 31, 2026
ImmuCell 2025 Net Loss Narrows Y/Y as Sales & Margins Improve
01:46pm, Friday, 06'th Mar 2026
ICCC's 2025 sales rise 4.3% y/y, with the gross margin expanding sharply, helping narrow its annual net loss despite asset write-downs and strategic shifts.
ImmuCell Corporation (ICCC) Q4 2025 Earnings Call Transcript
03:05pm, Thursday, 05'th Mar 2026
ImmuCell Corporation (ICCC) Q4 2025 Earnings Call Transcript
ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2025
04:05pm, Wednesday, 04'th Mar 2026
PORTLAND, Maine, March 04, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health company that develops, manufactures and markets product
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025
08:37am, Wednesday, 18'th Feb 2026
PORTLAND, Maine, Feb. 18, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health company that develops, manufactures and markets products
ImmuCell (NASDAQ:ICCC) Stock Passes Above Two Hundred Day Moving Average – Should You Sell?
03:18am, Saturday, 31'st Jan 2026
Shares of ImmuCell Corporation (NASDAQ: ICCC - Get Free Report) passed above its two hundred day moving average during trading on Friday. The stock has a two hundred day moving average of $6.11 and tr
Niche Focus & Regulation Shape the Future of Healthcare Firms
12:26pm, Thursday, 15'th Jan 2026
CPIX, NAII and ICCC lean into specialization, compliance and targeted growth to thrive in the niche healthcare markets.
ImmuCell Corporation (ICCC) Q4 2025 Sales/Trading Call Transcript
12:24pm, Friday, 09'th Jan 2026
ImmuCell Corporation (ICCC) Q4 2025 Sales/Trading Call Transcript
ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025
04:05pm, Thursday, 08'th Jan 2026
PORTLAND, Maine, Jan. 08, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health company that develops, manufactures and markets products
ImmuCell to Conduct Conference Call with Investors to Discuss Strategic Change in Focus
08:10am, Wednesday, 07'th Jan 2026
PORTLAND, Maine, Jan. 07, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health company that develops, manufactures and markets products
ImmuCell Announces Strategic Focus on First Defense® After Receiving an FDA Incomplete Letter for Re-Tain®
01:05pm, Wednesday, 24'th Dec 2025
PORTLAND, Maine, Dec. 24, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell”), an animal health company that develops, manufactures and markets products that improve cattle h
ImmuCell (NASDAQ:ICCC) Stock Passes Below 200-Day Moving Average – What’s Next?
05:30am, Tuesday, 16'th Dec 2025
ImmuCell Corporation (NASDAQ: ICCC - Get Free Report)'s share price crossed below its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $6.18 and traded as low
ImmuCell's Two-Product Edge in Cattle Health Fuels Growth
12:16pm, Thursday, 04'th Dec 2025
ICCC's innovative, antibiotic-free cattle health products drive margin recovery, real-world adoption and stock gains.
ICCC Stock Down Despite Y/Y Q3 Earnings Improvement & Margin Strength
08:46am, Thursday, 20'th Nov 2025
ImmuCell tumbles despite stronger margins and a rebound in EPS, as backlog dynamics pressure quarterly sales while management highlights improving operations.
ImmuCell Corporation (ICCC) Q3 2025 Earnings Call Transcript
11:01am, Friday, 14'th Nov 2025
ImmuCell Corporation ( ICCC ) Q3 2025 Earnings Call November 14, 2025 9:00 AM EST Company Participants Michael Brigham - Special Advisor to the CEO & Director P. F. Te Boekhorst - President, CEO & Dir
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2025
04:05pm, Thursday, 13'th Nov 2025
PORTLAND, Maine, Nov. 13, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets s
